Not available
Quote | Agios Pharmaceuticals Inc. (NASDAQ:AGIO)
Last: | $31.49 |
---|---|
Change Percent: | -0.09% |
Open: | $31.7 |
Close: | $31.49 |
High: | $32.01 |
Low: | $31.31 |
Volume: | 417,224 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Agios Pharmaceuticals Inc. (NASDAQ:AGIO)
CAMBRIDGE, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, May 2, 2024, at 8:00 a.m...
– Report Highlights Company’s Focus on Red Blood Cell Health; Diversity, Equity & Inclusion; and Strong Corporate Governance – – Aligns with the Sustainability Accounting Standards Board (SASB) Standards for the Biotechnology and Pharmaceuticals Industry ...
Message Board Posts | Agios Pharmaceuticals Inc. (NASDAQ:AGIO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $AGIO News Article - Agios to Webcast Conference Call of First Quarter 2023 Financial R | whytestocks | investorshangout | 04/13/2023 3:00:57 PM |
whytestocks: $AGIO News Article - Agios Appoints Rahul Ballal and Cynthia Smith to Board of Director | whytestocks | investorshangout | 08/15/2022 3:11:23 PM |
whytestocks: $AGIO News Article - Agios Reports Business Highlights and Second Quarter 2022 Financia | whytestocks | investorshangout | 08/04/2022 3:00:57 PM |
whytestocks: $AGIO News Article - Agios to Webcast Conference Call of Second Quarter 2022 Financial | whytestocks | investorshangout | 07/14/2022 2:40:52 PM |
whytestocks: $AGIO News Article - Agios Appoints Brian Goff as Chief Executive Officer | whytestocks | investorshangout | 07/12/2022 8:50:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Agios Pharmaceuticals Inc. Company Name:
AGIO Stock Symbol:
NASDAQ Market:
Agios Pharmaceuticals Inc. Website:
CAMBRIDGE, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, May 2, 2024, at 8:00 a.m...
– Report Highlights Company’s Focus on Red Blood Cell Health; Diversity, Equity & Inclusion; and Strong Corporate Governance – – Aligns with the Sustainability Accounting Standards Board (SASB) Standards for the Biotechnology and Pharmaceuticals Industry ...
2024-03-10 10:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...